Cargando…

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor

INTRODUCTION: As a group, rheumatoid arthritis (RA) patients exhibit increased risk of infection, and those treated with anti-tumor necrosis factor (TNF) therapy are at further risk. This increased susceptibility may result from a compromised humoral immune response. Therefore, we asked if short-ter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobie, James J, Zheng, Bo, Bryk, Peter, Barnes, Michael, Ritchlin, Christopher T, Tabechian, Darren A, Anandarajah, Allen P, Looney, R John, Thiele, Ralf G, Anolik, Jennifer H, Coca, Andreea, Wei, Chungwen, Rosenberg, Alexander F, Feng, Changyong, Treanor, John J, Lee, F Eun-Hyung, Sanz, Ignacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334662/ https://www.ncbi.nlm.nih.gov/pubmed/22177419 http://dx.doi.org/10.1186/ar3542

Ejemplares similares

Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response
por: Adlowitz, Diana G., et al.
Publicado: (2015)

Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
por: Rosenberg, Alexander, et al.
Publicado: (2014)

Two negative randomized controlled trials in lupus: now what?
por: Coca, Andreea, et al.
Publicado: (2009)

Advances in Human B Cell Phenotypic Profiling
por: Kaminski, Denise A., et al.
Publicado: (2012)

9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity
por: Kobie, James J., et al.
Publicado: (2012)

Failure of B Cell Tolerance in CVID
por: Richardson, Christopher T., et al.
Publicado: (2019)

Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques
por: Jaworski, Juan Pablo, et al.
Publicado: (2017)

Update on the use of rituximab for intractable rheumatoid arthritis
por: Looney, R John
Publicado: (2009)

Cell Senescence in Lupus
por: Gao, Lin, et al.
Publicado: (2019)

Polychromatic flow cytometry in evaluating rheumatic disease patients
por: Wei, Chungwen, et al.
Publicado: (2015)

B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation
por: Sun, Wen, et al.
Publicado: (2018)

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
por: Nogales, Aitor, et al.
Publicado: (2018)

Reconstitution of the adult B cell repertoire after treatment with rituximab
por: Sanz, Iñaki, et al.
Publicado: (2005)

Clonal associations of lymphocyte subsets and functional states revealed by single cell antigen receptor profiling of T and B cells in rheumatoid arthritis synovium
por: Dunlap, Garrett, et al.
Publicado: (2023)

Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis
por: Massey, Jonathan, et al.
Publicado: (2018)

Systemic lupus erythematosus is characterized by faulty B-cell tolerance in the germinal centers
por: Anolik, J, et al.
Publicado: (2004)

Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
por: Sanz, Ignacio, et al.
Publicado: (2019)

Two Major Autoantibody Clusters in Systemic Lupus Erythematosus
por: Ching, Kathryn H., et al.
Publicado: (2012)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

A Case Study Using a Behavioural Contract in Alcohol Dependence within a Crisis Home Treatment Team
por: Howe, Andrew John, et al.
Publicado: (2022)

Genome-Wide Association Study of Genetic Predictors of Anti–Tumor Necrosis Factor Treatment Efficacy in Rheumatoid Arthritis Identifies Associations with Polymorphisms at Seven Loci
por: Plant, Darren, et al.
Publicado: (2011)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
por: Alonso-Ruiz, Alberto, et al.
Publicado: (2008)

Co-Occurrence of Rheumatoid Arthritis and Lung Cancer—Coincidence or Not?
por: Munteanu, Ioana, et al.
Publicado: (2023)

ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells
por: Scharer, Christopher D., et al.
Publicado: (2016)

9G4+ Antibodies Isolated from HIV-Infected Patients Neutralize HIV-1 and Have Distinct Autoreactivity Profiles
por: Alcéna, Danielle C., et al.
Publicado: (2013)

Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor
por: Aberumand, Babak, et al.
Publicado: (2014)

Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
por: Desai, Rishi J., et al.
Publicado: (2014)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Lymphatic imaging to assess rheumatoid flare: mechanistic insights and biomarker potential
por: Rahimi, Homaira, et al.
Publicado: (2016)

Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
por: Park, Siyeon, et al.
Publicado: (2019)

The Chromatin Landscape of Pathogenic Transcriptional Cell States in Rheumatoid Arthritis
por: Weinand, Kathryn, et al.
Publicado: (2023)

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis
por: Bonetti, N. R., et al.
Publicado: (2019)

Using the UPOINT system to manage men with chronic pelvic pain syndrome
por: Bryk, Darren J., et al.
Publicado: (2021)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes
por: Zhang, Fan, et al.
Publicado: (2023)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort
por: Plant, Darren, et al.
Publicado: (2012)

Lack of association of –863C/A (rs1800630) polymorphism of tumor necrosis factor-a gene with rheumatoid arthritis
por: Sadaf, Tayyaba, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oqd3e1bfgkvnbh64s20d2g6pmo